| Basics |
Seres Therapeutics, Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company which is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics.
|
| IPO Date: |
June 26, 2015 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$150.72M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.39 | 3.73%
|
| Avg Daily Range (30 D): |
$1.16 | 6.31%
|
| Avg Daily Range (90 D): |
$0.84 | 4.69%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.02M |
| Avg Daily Volume (30 D): |
.2M |
| Avg Daily Volume (90 D): |
.16M |
| Trade Size |
| Avg Trade Size (Sh.): |
166 |
| Avg Trade Size (Sh.) (30 D): |
73 |
| Avg Trade Size (Sh.) (90 D): |
73 |
| Institutional Trades |
| Total Inst.Trades: |
1,294 |
| Avg Inst. Trade: |
$1.88M |
| Avg Inst. Trade (30 D): |
$.67M |
| Avg Inst. Trade (90 D): |
$.65M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.2M |
| Avg Closing Trade (30 D): |
$.66M |
| Avg Closing Trade (90 D): |
$.66M |
| Avg Closing Volume: |
12.55K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$.31
|
$.94
|
$-2.27
|
|
Diluted EPS
|
$.3
|
$.94
|
$-2.27
|
|
Revenue
|
$ .35M
|
$ .35M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ 5.39M
|
$ 8.2M
|
$ -19.86M
|
|
Operating Income / Loss
|
$ -103.43M
|
$ -22.48M
|
$ -24.88M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -20.39M
|
$ 2.26M
|
$ -13.47M
|
|
PE Ratio
|
58.33
|
|
|
| Splits |
|
Apr 22, 2025:
1:20
|
|
|
|
